Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Turk J Urol ; 48(4): 254-261, 2022 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-35913440

RESUMEN

About 275 million people worldwide aged between 15 and 64 years used drugs at least once since 2016. Initial estimations suggest that 13.8 million young people between 15 and 16 years used cannabis every year. Recreational drug use contributes significantly to mortality as well as physical and mental health problems. A number of urological complications can arise from the use of common and emerging recreational drugs which can present as wide spectrum affecting lower and upper urinary tracts, kidneys, sexual organs as well as sexual dysfunction. In order to effectively manage these issues, urologists need to be cognizant of these complications in their patients, particularly among youths. This review attempted to consolidate available data and provide insight into this issue; however, further population-based epidemiological studies are needed to provide necessary guidelines.

2.
JRSM Open ; 12(2): 2054270420983105, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33680481

RESUMEN

Advanced and metastatic prostate cancer is often managed with hormonal blockage. Luteinising hormone-releasing hormone antagonists achieve rapid testosterone suppression and are used for the treatment of advanced or metastatic prostate cancer. Degarelix is a luteinising hormone-releasing hormone antagonist and is given as a loading dose, followed by a monthly maintenance dose. We report a case where a patient was inadvertently given a second loading dose of Degarelix that resulted in acute psychosis in the form of panic attacks, delusions, suicidal thoughts, insomnia and some visual hallucinations, which are not reported as side-effects of Degarelix.

3.
BJUI Compass ; 2(6): 385-394, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35474702

RESUMEN

Objectives: Objective of this study is to report the results of nurse led hematuria clinic service outcome of 2,714 patients. Subjects and methods: We conducted a retrospective, single center review of 2714 patients with visible and nonvisible hematuria managed by a well-trained nurse specialist in a rapid access clinic (RAC) between 2014 and 2020. All patients received a full review, flexible cystoscopy performed by a nurse, and ultrasound of urinary tracts. After investigations, patients were reassured and discharged or referred for rigid cystoscopy, TURBT, and CT urography. Results: In total, 2714 patients attended the RAC between October 2014 and March 2020. Of these, 1684 (62%) were males and 1030 (38%) females. The median age of patients was 68.3 (IQR 58-79). Of the 1030 females, 500 (48.5%) presented with nonvisible hematuria (NVH), and 530 (51.5%) presented with visible hematuria (VH). The median age was 66 (IQR 56-76). The number of females diagnosed with any form of malignancy was 72 (7% of all females). Of the 1684 males, 288 (17.1%) presented with NVH, and 1396 (82.9%) presented with VH. The median age was 72 (IQR 59-81). The number of males diagnosed with some form of malignancy was 258 (15.3% of all males). Overall, 1926 patients presented with VH and 788 patients presented with NVH. After investigations, 290 patients (15.1%) with VH and 40 (5.1%) patients with NVH had some form of malignancy. The highest number of malignancies found in VH was bladder cancer (n = 222, 11.5%), followed by prostate (n = 28, 1%), renal (n = 23, 0.8%), UT urothelial (n = 17, 0.6%), gynaecological (n = 7, 0.3%), and gastrointestinal (n = 5, 0.2%) cancer. The highest number of pathologies found in NVH was infection (n = 44, 5.6%). Cancer detection rate for symptomatic NVH was more than double that of asymptomatic NVH, 6.5% versus 3.1%, respectively. Conclusion: Overall, 15.1% with VH and 5.1% with NVH present with malignancy. Nurse-led rapid access hematuria clinic and flexible cystoscopy investigation by trained nurse is safe and feasible.

4.
Cureus ; 12(2): e7099, 2020 Feb 25.
Artículo en Inglés | MEDLINE | ID: mdl-32190520

RESUMEN

Horseshoe kidney (HSK) is the common renal fusion congenital anomaly, affecting about 0.25% of the global population. Although most HSKs are detected incidentally, they may present with clinical findings, including urinary tract infections (UTI), stone formation, and obstruction. Nephrolithiasis, observed in 20% of patients with HSK, is a frequent indication for surgery. Due to the caudal and medial locations of calyces and the abnormal anterior position of the kidney, extracorporeal shock wave lithotripsy has shown a relatively low success rate in treating HSK. Percutaneous nephrolithotomy has also been associated with major complications in anomalous kidneys. Advances in laparoscopic instrumentation and techniques have made laparoscopic surgery a promising alternative for stone treatment in HSK. This report describes a 61-year-old woman who presented initially with recurrent UTI unresponsive to multiple courses of antibiotics. Urine cultures were positive for Escherichia coli. A computed tomography scan showed a right HSK with multiple renal stones (35 mm in the right lower pole with eight stones 2-4 mm in size), along with severe hydronephrosis. The patient was treated successfully with laparoscopic nephrolithotomy, indicating that laparoscopy is an effective and safe approach in the treatment of renal stones >2 cm in HSK.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA